1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "2379-57-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-15067

    FG 9041

    iGluR Cancer
    DNQX (FG 9041), a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively).